Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8924 |
High Similarity |
NPD7228 |
Approved |
0.8836 |
High Similarity |
NPD6674 |
Discontinued |
0.8718 |
High Similarity |
NPD6234 |
Discontinued |
0.8636 |
High Similarity |
NPD37 |
Approved |
0.859 |
High Similarity |
NPD4967 |
Phase 2 |
0.859 |
High Similarity |
NPD4966 |
Approved |
0.859 |
High Similarity |
NPD4965 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8414 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8414 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8194 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8138 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8079 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8072 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8037 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8014 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7966 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7655 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7561 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7416 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7378 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD6842 |
Approved |
0.736 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.736 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7263 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7207 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7184 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7168 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7168 |
Intermediate Similarity |
NPD27 |
Approved |
0.716 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7135 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7133 |
Intermediate Similarity |
NPD228 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD2969 |
Approved |
0.711 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7079 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7059 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7059 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7039 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6190 |
Approved |
0.6993 |
Remote Similarity |
NPD3021 |
Approved |
0.6993 |
Remote Similarity |
NPD3022 |
Approved |
0.6987 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD4538 |
Approved |
0.6981 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD4536 |
Approved |
0.6975 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD3092 |
Approved |
0.6947 |
Remote Similarity |
NPD7697 |
Approved |
0.6947 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD7698 |
Approved |
0.6941 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD7157 |
Approved |
0.6933 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3750 |
Approved |
0.6933 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6696 |
Suspended |
0.6928 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1512 |
Approved |
0.6923 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4097 |
Suspended |
0.6914 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6911 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6911 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6905 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6891 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.689 |
Remote Similarity |
NPD2677 |
Approved |
0.6882 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7801 |
Approved |
0.6872 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD2533 |
Approved |
0.6867 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD2534 |
Approved |
0.6867 |
Remote Similarity |
NPD2532 |
Approved |
0.6864 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.686 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6855
|
Remote Similarity |
NPD6355 |
Discontinued |